Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines
Open Access
Abstract
This study aimed to observe adverse events following immunisation (AEFIs) that affected recovery within two weeks after COVID-19 vaccination and investigate their risks in propensity-score-matched populations. Data were collected from 447,346 reports from the VAERS between 1 January 2021 and 31 July 2021. Propensity-score-matched populations were constructed by adjusting for demographic characteristics and 11 underlying diseases in eligible subjects who received 1 of 3 COVID-19 vaccines: 19,462 Ad26.COV2.S, 120,580 mRNA-1273, and 100,752 BNT162b2. We observed that 88 suspected AEFIs (22 in Ad26.COV2.S, 62 in mRNA-1273, and 54 in BNT162b2) were associated with an increased risk of delayed recovery within 2 weeks after COVID-19 vaccinations. Nervous system, musculoskeletal and connective tissue, gastrointestinal, skin, and subcutaneous tissue disorders were the most common AEFIs after COVID-19 vaccination. Interestingly, four local and systemic reactions affected recovery in different vaccine recipients during our study period: asthenic conditions and febrile disorders in Ad26.COV2.S and mRNA-1273; general signs and symptoms in mRNA-1273 and BNT162b2; injection site reactions in Ad26.COV2.S and BNT162b2. Although it is necessary to confirm a causal relationship with COVID-19 vaccinations, some symptoms, including paralysis, allergic disorders, breathing abnormalities, and visual impairment, may hinder the recovery of these recipients.Keywords
Funding Information
- Ministry of Trade, Industry and Energy (10077260)
- National Research Foundation of Korea (NRF) (2020R1A6A1A03040516)
- Ministry of Science and ICT of Korea (21‒DPIC‒15)
This publication has 46 references indexed in Scilit:
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)Vaccine, 2015
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposiumJournal of Allergy and Clinical Immunology, 2006
- Understanding vaccine safety information from the Vaccine Adverse Event Reporting SystemThe Pediatric Infectious Disease Journal, 2004
- Using MedDRADrug Safety, 2004
- Medical Dictionary for Regulatory Activities (MedDRA)*International Journal of Pharmaceutical Medicine, 2004
- A Solution to the Problem of Monotone Likelihood in Cox RegressionBiometrics, 2001
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994